CRISPR/Cas9-Mediated Point Mutation in Nkx3.1 Prolongs Protein Half-Life and Reverses Effects Nkx3.1 Allelic Loss.

Authors

Cai Bowen
Maho Shibata, George Washington University
Hailan Zhang
Sarah K Bergren
Michael M Shen
Edward P Gelmann

Document Type

Journal Article

Publication Date

9-17-2020

Journal

Cancer Research

DOI

10.1158/0008-5472.CAN-20-1742

Comments

Online ahead of print

APA Citation

Bowen, C., Shibata, M., Zhang, H., Bergren, S., Shen, M., & Gelmann, E. (2020). CRISPR/Cas9-Mediated Point Mutation in Nkx3.1 Prolongs Protein Half-Life and Reverses Effects Nkx3.1 Allelic Loss.. Cancer Research, (). http://dx.doi.org/10.1158/0008-5472.CAN-20-1742

Peer Reviewed

1